Sop For Diagnosis Of Top 20 Common Diseases Updated (WORKING × 2026)

Abnormal serum concentrations of cholesterol fractions and/or triglycerides. Diagnostic Tools & Labs:

Annual assessment for microalbuminuria, retinopathy, and neuropathy. Hypothyroidism: Protocol: High TSH ( >4.5is greater than 4.5 mIU/L), Low Free T4.

Recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early morning.

Chief Medical Officer Director of Clinical Quality Assurance sop for diagnosis of top 20 common diseases updated

This Standard Operating Procedure (SOP) defines the mandatory diagnostic pathways for the 20 most frequently encountered clinical conditions in primary and secondary care. It aims to standardize diagnostic accuracy, minimize practitioner variance, optimize resource utilization, and incorporate the latest evidence-based guidelines up to 2026. This document applies to all attending physicians, residents, nurse practitioners, and clinical laboratory staff. 2. General Diagnostic Principles

Dysuria, urinary frequency, urgency, suprapubic pain, and hematuria, without vaginal discharge or irritation.

Obtain a random spot urine specimen to check the albumin-to-creatinine ratio (UACR). requiring healthcare providers to adopt standardized

Your (e.g., primary care clinic, emergency department, regional hospital)

Consider in patients over 40 with chronic cough, progressive dyspnea, sputum production, or a history of tobacco exposure.

Rheumatoid Factor (RF) and Anti-Cyclic Citrullinated Peptide (anti-CCP) antibodies. evidence-based approaches to ensure accurate

Alpha-1 antitrypsin screening in patients presenting under the age of 45 or with a strong family history.

The landscape of medical diagnostics is constantly evolving, requiring healthcare providers to adopt standardized, evidence-based approaches to ensure accurate, timely, and cost-effective patient care. This updated Standard Operating Procedure (SOP) outlines the diagnostic protocols for the top 20 most common diseases encountered in primary care and general medicine for 2026, incorporating advancements in rapid diagnostics, AI-assisted imaging, and updated screening guidelines.